C.R. Bard To Be Bought By Becton Dickinson For $24B
Medical device companies C.R. Bard Inc. and Becton, Dickinson and Co. (BD) will merge in a $24 billion cash and stock deal, the companies announced April 23....To view the full article, register now.
Already a subscriber? Click here to view full article